Judge Allows Aredia Plaintiffs To Alter Complaint

The federal judge presiding over the multidistrict litigation involving bone cancer drugs Aredia and Zometa has given the plaintiffs his blessing to amend their complaint once again. The charge that the...

Already a subscriber? Click here to view full article